Ledger.Open graph →
SEC Form D · filed June 18, 2018

Lung Therapeutics, Inc

Offering
Sold
Exemption
Rule 506(b)
Industry
Pharmaceuticals
Location
Austin, TX
Type

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (15)

Aaron B. Fletcher · Carrollton, TXDirectorSteven B. Idell · Tyler, TXDirectorRobert B. Mills · Naples, FLDirectorJames B. Windsor · Austin, TXExec · DirectorJim B. Mervis · Los Angeles, CADirectorCatherine Bingham · London, United KingdomDirectorRichard B. Cook · Stevensville, MDExec · DirectorAlexandra Hess · London, United KingdomDirectorKathryn Stewart · LARKSPUR, CADirectorHamish Cameron · London, United KingdomDirectorMichael Ross · London, United KingdomDirectorMark Schulman · Greenwood Village, CODirectorTimothy Chklovski · Los Angeles, CADirectorMichael Dineen · Campbell, CAExec · DirectorBarrett Brown · New York, NYDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗